Literature DB >> 6965443

Isolation of an ampicillin-resistant, non-beta-lactamase-producing strain of Haemophilus influenzae.

S M Markowitz.   

Abstract

A 79-year-old female developed endocarditis and meningitis due to an ampicillin-resistant, non-beta-lactamase-producing strain of Haemophilus influenzae. Carbenicillin and gentamicin therapy resulted in bacteriological and clinical cure. The mechanism of resistance of ampicillin-resistant, non-beta-lactamase-producing strains of H. influenzae is unknown.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6965443      PMCID: PMC283729          DOI: 10.1128/AAC.17.1.80

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

1.  Antibiotic sensitivity testing. Report of an international collaborative study.

Authors:  H M Ericsson; J C Sherris
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1971

2.  Origin of the TEM-beta-lactamase gene found on plasmids.

Authors:  F Heffron; R Sublett; R W Hedges; A Jacob; S Falkow
Journal:  J Bacteriol       Date:  1975-04       Impact factor: 3.490

3.  Meningitis and bacteremia due to Haemophilus influenzae: occurrence and mortality at Boston City Hospital in 12 selected years, 1935-1972.

Authors:  J E McGowan; J O Klein; L Bratton; M W Barnes; M Finland
Journal:  J Infect Dis       Date:  1974-08       Impact factor: 5.226

4.  Plasmid-linked ampicillin resistance in haempohilus influenza type b.

Authors:  L P Elwell; J De Graaff; D Seibert; S Falkow
Journal:  Infect Immun       Date:  1975-08       Impact factor: 3.441

5.  R-factor mediated beta-lactamase production by Haemophilus influenzae.

Authors:  R B Sykes; M Matthew; C H O'Callaghan
Journal:  J Med Microbiol       Date:  1975-08       Impact factor: 2.472

6.  Susceptibility of Haemophilus influenzae isolates from blood and cerebrospinal fluid to ampicillin, chloramphenicol, and trimethoprim-sulfamethoxazole.

Authors:  J E McGowan; P M Terry; A J Nahmias
Journal:  Antimicrob Agents Chemother       Date:  1976-01       Impact factor: 5.191

7.  Susceptibility of ampicillin-resistant Haemophilus influenzae to seven penicillins.

Authors:  C Thornsberry; C N Baker; L A Kirven; J M Swenson
Journal:  Antimicrob Agents Chemother       Date:  1976-01       Impact factor: 5.191

8.  Simple agarose gel electrophoretic method for the identification and characterization of plasmid deoxyribonucleic acid.

Authors:  J A Meyers; D Sanchez; L P Elwell; S Falkow
Journal:  J Bacteriol       Date:  1976-09       Impact factor: 3.490

9.  Iodometric detection of Haemophilus influenzae beta-lactamase: rapid presumptive test for ampicillin resistance.

Authors:  B W Catlin
Journal:  Antimicrob Agents Chemother       Date:  1975-03       Impact factor: 5.191

10.  Ampicillin-resistant Haemophilus influenzae type B possessing a TEM-type beta-lactamase but little permeability barrier to ampicillin.

Authors:  A A Medeiros; T F O'Brien
Journal:  Lancet       Date:  1975-03-29       Impact factor: 79.321

View more
  35 in total

1.  Identification of beta-lactamase-negative, ampicillin-resistant strains of Haemophilus influenzae with four methods and eight media.

Authors:  A L Barry; P C Fuchs; S D Brown
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

2.  Antimicrobial surveillance of Haemophilus influenzae in the United States during 2000-2001 leads to detection of clonal dissemination of a beta-lactamase-negative and ampicillin-resistant strain.

Authors:  James A Karlowsky; Ian A Critchley; Renée S Blosser-Middleton; Elena A Karginova; Mark E Jones; Clyde Thornsberry; Daniel F Sahm
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

Review 3.  In vitro antibacterial activity and pharmacodynamics of new quinolones.

Authors:  A Dalhoff; F-J Schmitz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-04-01       Impact factor: 3.267

4.  Association of amino acid substitutions in penicillin-binding protein 3 with beta-lactam resistance in beta-lactamase-negative ampicillin-resistant Haemophilus influenzae.

Authors:  K Ubukata; Y Shibasaki; K Yamamoto; N Chiba; K Hasegawa; Y Takeuchi; K Sunakawa; M Inoue; M Konno
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

5.  Genetic and molecular characterization of beta-lactamase-negative ampicillin-resistant Haemophilus influenzae with unusually high resistance to ampicillin.

Authors:  Frank S Kaczmarek; Thomas D Gootz; Fadia Dib-Hajj; Wenchi Shang; Shawn Hallowell; Melissa Cronan
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

6.  Epidemiology and evolution of antibiotic resistance of Haemophilus influenzae in children 5 years of age or less in France, 2001-2008: a retrospective database analysis.

Authors:  H Dabernat; C Delmas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-04-27       Impact factor: 3.267

Review 7.  Haemophilus influenzae: antibiotic susceptibility.

Authors:  C A Needham
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

8.  Ampicillin-resistant non-beta-lactamase-producing Haemophilus influenzae in Spain: recent emergence of clonal isolates with increased resistance to cefotaxime and cefixime.

Authors:  Silvia García-Cobos; José Campos; Edurne Lázaro; Federico Román; Emilia Cercenado; César García-Rey; María Pérez-Vázquez; Jesús Oteo; Francisco de Abajo
Journal:  Antimicrob Agents Chemother       Date:  2007-04-30       Impact factor: 5.191

9.  Simple screening method for beta-lactamase-positive and -negative ampicillin-resistant Haemophilus influenzae isolates.

Authors:  T R Parr; C H Pai; L E Bryan
Journal:  J Clin Microbiol       Date:  1984-07       Impact factor: 5.948

10.  Rapidly increasing prevalence of beta-lactamase-nonproducing, ampicillin-resistant Haemophilus influenzae type b in patients with meningitis.

Authors:  Keiko Hasegawa; Naoko Chiba; Reiko Kobayashi; Somay Y Murayama; Satoshi Iwata; Keisuke Sunakawa; Kimiko Ubukata
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.